Tagrisso News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Tagrisso. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Tagrisso Today - Breaking & Trending Today
Drugmaker AstraZeneca traded higher early on Monday after revealing that a combination of its cancer drug Tagrisso with chemotherapy had gained US approval to treat a particular type of lung cancer. ....
The drug would be used to treat adults with a type of advanced lung cancer, AstraZeneca said, adding that the FDA s approval was based on trials which extended median progression-free survival (PFS) by nearly nine months. ....
A study suggests that human papillomavirus (HPV) screenings should be updated due to effective HPV vaccines; a new study shows that osimertinib (Tagrisso, AstraZeneca) reduced both the 5-year risk of recurrent cancer and the risk of death in patients with stage 1B to 3A lung cancer; a new smartphone-controlled technology could help those who suffer from migraines. ....
The combination of amivantamab and lazertinib reduced the risk of disease progression or death by 30% compared with osimertinib alone as frontline therapy for patients with advanced non–small cell lung cancer harboring classical EGFR sensitizing mutations. ....